Coxsackievirus-Induced Cardiomyopathy Treatment- Cardiology
Disclaimer: Please note that Mya Care does not provide medical advice, diagnosis, or treatment. The information provided is not intended to replace the care or advice of a qualified health care professional. Always consult your doctor for all diagnoses, treatments, and cures for any diseases or conditions, as well as before changing your health care regimen. Do not reproduce, copy, reformat, publish, distribute, upload, post, transmit, transfer in any manner or sell any of the materials on this page without the prior written permission from myacare.com.
Coxsackievirus-induced cardiomyopathy is due to RNA enteroviruses. It is caused by coxsackieviruses, which can further cause serious myocarditis, further leading to dilated cardiomyopathy.
Dilated cardiomyopathy in people can be brought about by numerous factors that include genetic deficiencies in the cytoskeletal protein dystrophin, such as in Duchenne muscular dystrophy (DMD) patients. The heart having dilated cardiomyopathy has enlargement of ventricles which can further lead to heart failure.
Coxsackievirus B virus-induced cardiomyopathy makes up about 30% of the cases of dilated cardiomyopathy in people.
Why is coxsackievirus-induced cardiomyopathy treatment required?
Most viral infection can be avoided and prevented by maintaining proper hygiene. Washing your hands in a timely manner and proper sanitation can stop fecal-oral transmission of viruses.
Analgesics can help reduce inflammation so you can be able to manage myocarditis. They may also limit the occurrence of heart damage.
Heart function can be affected by myocarditis. Heart failure will most likely occur due to lack of oxygen. A heart transplant can be done in severe cases of myocarditis.
Which doctor to consult
Talk to a cardiologist, who will explain to you about the treatments, the risks and after-care.
What to expect during coxsackievirus-induced cardiomyopathy treatment
Immunosuppressive agents, IVIG, antiviral drugs, and other medications have been utilized in the treatment of myocarditis. In any case, the effectiveness of these treatments has not been well recognized, because studies have not distinguished between infectious and non-infectious forms of myocarditis. This makes it hard to extrapolate study results in viral myocarditis.
- Coxsackievirus-induced cardiomyopathy. (2019). Retrieved from https://en.wikipedia.org/wiki/Coxsackievirus-induced_cardiomyopathy
- Treatment of Viral Myocarditis Caused by Coxsackievirus B. (2019). Retrieved from https://www.medscape.com/viewarticle/571656_4